Batavia Bioservices BV

With facilities in the Netherlands and Massachusetts, Batavia Bioservices is a high quality CRO/CMO with strong product development know-how that has enabled us to develop technologies to accelerate viral, viral vector and bacterial vaccine development from discovery to. Our capabilities support activities from target discovery and screening, production of research materials and reagents up to full GMP IND trajectory support for recombinant proteins, vaccines and vectors. 

Traditionally this area has been limited by lack of scale-down models to mimic the challenges of adherent cell culture systems and evaluate product characteristics. Designed to overcome this limitation Batavia Bioservices offers the  SCOUT™ technology an integrated platform of scaled-down model systems which together make multivariable studies an affordable solution for process optimisation.

Some of our high throughput vaccine projects:
•    Influenza/ MDCK microcarriers
•    Polio/ VERO micro carriers 
•    West Nile virus growth on proprietary client cell platform
•    RSV virus growth optimization on VERO microcarriers

Viral vector projects include Bill & Melinda Gates funded HIV projects and the following:
•    Generation of Ad vector 
•    Generation of pre-MVS 
•    GMP production and characterisation
•    Assays for product characterization, release and stability